CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

  • Janine Morales
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Bernhard Homey
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Alain P. Vicari
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Susan Hudak
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Elizabeth Oldham
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Joseph Hedrick
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Rocio Orozco
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Neal G. Copeland
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Nancy A. Jenkins
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Leslie M. McEvoy
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702
  • Albert Zlotnik
    Department of Immunobiology, DNAX Research Institute, Palo Alto, CA 94304; Schering-Plough, Laboratory for Immunological Research, Dardilly, France; Schering-Plough Research Institute, Human Genome Research, Kenilworth, NJ 07033; Instituto Nacional de la Nutrición, México D.F., México; and Mammalian Genetics Laboratory, National Cancer Institute–Frederick Cancer Research and Development Center, Frederick, MD 21702

抄録

<jats:p>In contrast to naive lymphocytes, memory/effector lymphocytes can access nonlymphoid effector sites and display restricted, often tissue-selective, migration behavior. The cutaneous lymphocyte-associated antigen (CLA) defines a subset of circulating memory T cells that selectively localize in cutaneous sites mediated in part by the interaction of CLA with its vascular ligand E-selectin. Here, we report the identification and characterization of a CC chemokine, cutaneous T cell-attracting chemokine (CTACK). Both human and mouse CTACK are detected only in skin by Southern and Northern blot analyses. Specifically, CTACK message is found in the mouse epidermis and in human keratinocytes, and anti-CTACK mAbs predominantly stain the epithelium. Finally, CTACK selectively attracts CLA<jats:sup>+</jats:sup>memory T cells. Taken together, these results suggest an important role for CTACK in recruitment of CLA<jats:sup>+</jats:sup>T cells to cutaneous sites. CTACK is predominantly expressed in the skin and selectively attracts a tissue-specific subpopulation of memory lymphocytes.</jats:p>

収録刊行物

被引用文献 (20)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ